Belgian Pharma Stock News

KBC Group NV has reported full-year 2025 net income of €3.57 billion and earnings per share of €8.70, and its Board has proposed a total gross dividend of €5.10 per share for 2025, including an interim €1.00 already paid and a planned €4.10 payout in May 2026, equating to a 60% pay-out ratio including the additional tier-1 coupon. Alongside these results, KBC Bank’s move to offer crypto trading on its Bolero platform via Crypto Finance marks a meaningful expansion of its digital investment...

Why Anheuser-Busch InBev (ENXTBR:ABI) Is Back on Investors’ Radar Anheuser-Busch InBev (ENXTBR:ABI) is drawing fresh attention after releasing its fourth quarter and full year 2025 results, proposing a full year dividend of €1.15 per share, and completing a $635 million share buyback. See our latest analysis for Anheuser-Busch InBev. Those earnings, dividend and buyback announcements have landed alongside strong recent momentum, with a 30 day share price return of 15.06% and a 90 day share...

If you are wondering whether argenx is priced attractively or already baking in a lot of optimism, you are not alone. This article is written with that exact question in mind. argenx shares last closed at €714.40, with returns of 1.9% over 7 days, 6.1% over 30 days, a 1.3% decline year to date, and 15.5% over the past year, while the 3 year and 5 year returns stand at 108.0% and 151.9% respectively. Recent headlines around argenx have kept attention on its share price, including ongoing...

Dividend and earnings announcement Lotus Bakeries (ENXTBR:LOTB) has drawn fresh attention after reporting full year 2025 results, with sales of €1,355.06m and net income of €172.26m, alongside an annual dividend of €63.00 per share. See our latest analysis for Lotus Bakeries. The full year earnings and dividend news comes after a strong run, with a 30 day share price return of 12.53% and a 90 day share price return of 33.68% suggesting positive momentum. The 1 year total shareholder return of...

Why Fagron’s latest earnings matter for shareholders Fagron (ENXTBR:FAGR) has just reported full year 2025 results, held its earnings call, raised its proposed dividend to €0.40 per share, and outlined guidance for 2026 that points to continued organic growth and slightly higher profitability. For you as an investor, that combination of reported numbers, a higher cash payout, and forward looking guidance offers fresh information about how the business is performing today and how management is...

As European markets experience volatility amid global economic shifts, the pan-European STOXX Europe 600 Index recently hit a new high but ended the week with only a slight gain of 0.09%. This backdrop of fluctuating investor sentiment and economic expansion in key regions like the eurozone presents an intriguing environment for uncovering lesser-known stocks that might offer unique opportunities. In such conditions, identifying stocks with strong fundamentals and potential resilience to...

Why Aedifica/SA (ENXTBR:AED) is back on income investors’ radar Aedifica/SA (ENXTBR:AED) has drawn fresh attention after confirming a proposed gross dividend of €4.00 per share for May 2026, alongside full year 2025 results showing higher sales, net income and earnings per share. See our latest analysis for Aedifica/SA. The confirmation of the proposed €4.00 dividend and stronger 2025 results come after an 18.45% 90-day share price return and a 36.72% 1-year total shareholder return,...

Cmb.Tech (ENXTBR:CMBT) has agreed to sell two VLCCs, Ingrid and Ilma. The transaction is expected to generate an approximate US$98.2 million capital gain recorded in the second quarter of 2026. See our latest analysis for Cmb.Tech. The vessel sale headlines arrive as Cmb.Tech's share price trades at €11.22, with a 30-day share price return of 11.53% and a 90-day share price return of 33.57%. The 1-year total shareholder return of 17.80% sits against a 5-year total shareholder return of...

Barco (ENXTBR:BAR) has released its full year 2025 results, reporting sales of €963.84 million and net income of €71.56 million. These figures help frame the recent share performance. See our latest analysis for Barco. Despite the solid full year 2025 figures, Barco’s share price has softened, with a 30 day share price return of an 11.79% decline and a 1 year total shareholder return of a 4.9% loss, suggesting momentum has been fading recently. If these results have you thinking about where...

If you are trying to work out whether Solvay shares at €27.84 are starting to look attractively priced, you are in the right place. The stock has returned 4.0% over the last 7 days and 2.7% over the past month, while the 1 year return sits at a 9.2% decline, compared with longer term returns of 44.3% over 3 years and 73.9% over 5 years. These moves come against a backdrop where investors have been reassessing Solvay's positioning in the materials sector and its portfolio after previous...

If you are wondering whether SCR-Sibelco is priced fairly today, you are not alone. The stock often attracts attention from investors trying to work out if they might be overpaying or missing an opportunity. Over the short term, the share price has been mixed, with a 1.3% return over the last 7 days, a 0.8% decline over 30 days, and returns of 12.7% decline year to date and 5.7% decline over the past year, extending to a 10.9% decline over five years. Recent news coverage has mainly focused...

Key Insights Significant control over Biotalys by private equity firms implies that the general public has more power...

As European markets experience volatility amid global concerns about AI disruption, the pan-European STOXX Europe 600 Index has managed to reach new highs, reflecting a cautiously optimistic sentiment. In this dynamic environment, identifying promising stocks requires a keen understanding of market trends and economic indicators that can reveal potential growth opportunities.

As European markets experience volatility amid global concerns over AI disruption, the pan-European STOXX Europe 600 Index managed to hit a new high, ending the week with a slight gain. In such an environment, dividend stocks can offer investors a degree of stability and income potential, making them attractive options for those looking to navigate uncertain market conditions.

Montea Comm. VA overview Montea Comm. VA (ENXTBR:MONT) is back in focus after investors reacted to its recent share performance, with the stock showing mixed returns over the past week, month and past 3 months. The logistics focused real estate group, active across Belgium, the Netherlands, France and Germany, now trades around €74. This has prompted fresh interest in how its long term total returns compare with its current valuation profile. See our latest analysis for Montea Comm...

Aedifica/SA (ENXTBR:AED) has wrapped up FY 2025 with fourth quarter revenue of €90.5 million and basic EPS of €1.06. Trailing 12 month figures show revenue of €369.6 million and EPS of €5.14. The company has reported revenue increasing from €346.5 million to €369.6 million on a trailing 12 month basis, with EPS rising from €4.31 to €5.14 over the same period. Quarterly revenue ranged between €90.2 million and €95.4 million, and EPS between €0.71 and €1.70 across the last six reported...

It's been a good week for Anheuser-Busch InBev SA/NV ( EBR:ABI ) shareholders, because the company has just released...

Shareholders might have noticed that KBC Group NV ( EBR:KBC ) filed its yearly result this time last week. The early...

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...

Competitive pressure in generalized myasthenia gravis The European Commission’s approval of Amgen’s Uplizna for generalized myasthenia gravis puts fresh competitive pressure on UCB (ENXTBR:UCB) in a treatment area where it already markets RYSTIGGO and ZILBRYSQ. See our latest analysis for UCB. Against this backdrop of fresh competition in generalized myasthenia gravis, UCB’s share price has climbed to €279.5, with a 90 day share price return of 22.27% and a 1 year total shareholder return of...

Recent share performance and current snapshot SCR-Sibelco (ENXTBR:094426466) has been relatively stable in the very short term, with the share price flat over the past day and a modest 1.3% gain over the past week. Over longer periods, the picture is more mixed, with a small decline over the past month, a 3% gain over the past 3 months, and negative returns year to date and over the past year and the past 3 to 5 years. See our latest analysis for SCR-Sibelco. That mix of a 3.03% 90 day share...

Orange Belgium S.A.'s ( EBR:OBEL ) solid earnings announcement recently didn't do much to the stock price. Our analysis...

Most readers would already be aware that Cenergy Holdings' (EBR:CENER) stock increased significantly by 30% over the...

Sipef (ENXTBR:SIP) has reported fresh FY 2025 numbers, with first half revenue of US$250.4 million and EPS of US$5.54, set against trailing 12 month revenue of US$570.4 million and EPS of US$12.05 that came with 90.5% earnings growth over the past year. The company has seen revenue move from US$203.1 million and EPS of US$2.41 in 1H 2024 to US$239.3 million and EPS of US$3.91 in 2H 2024, before reaching the latest 1H 2025 levels. This progression gives investors a clearer run rate on both the...